HealthEquity (HQY)

• Market cap: $8.17B
• 1 day: -2.75%
• 5 days: -6.61%
• 1 month: -9.60%
• 3 months: 14.99%
• 6 months: -7.17%
• Year to date: -2.37%
• 1 year: 24.81%
• 5 years: 63.22%
• 10 years: 186.51%
• Sector: Healthcare
• Industry: Health Information Services

About: HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

Employees: 3,120

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

62% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 47

40% more funds holding in top 10

Funds holding in top 10: 5 [Q4 2024] → 7 (+2) [Q1 2025]

39% more repeat investments, than reductions

Existing positions increased: 194 | Existing positions reduced: 140

5% more funds holding

Funds holding: 438 [Q4 2024] → 459 (+21) [Q1 2025]

2.22% more ownership

Funds ownership: 104.03% [Q4 2024] → 106.26% (+2.22%) [Q1 2025]

2% less call options, than puts

Call options by funds: $27.5M | Put options by funds: $28M

6% less capital invested

Capital invested by funds: $8.65B [Q4 2024] → $8.1B (-$549M) [Q1 2025]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $100 6% upside
• Avg. target: $115 22% upside
• High target: $125 32% upside

8 analyst ratings

• positive: 7 88%
• neutral: 1 13%
• negative: 0 0%

Raymond James C. Gregory Peters	27% upside $120	Strong Buy Reiterated	8 Jul 2025
Barrington Research Alexander Paris	32% upside $125	Outperform Maintained	5 Jun 2025
Deutsche Bank George Hill	22% upside $115	Buy Maintained	5 Jun 2025
Goldman Sachs David Roman	10% upside $104	Neutral Maintained	4 Jun 2025
RBC Capital Daniel Perlin	24% upside $117	Outperform Maintained	4 Jun 2025